Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kasiewicz, Lisa N.
14  Ergebnisse:
Personensuche X
?
1

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepati..:

Kasiewicz, Lisa N. ; Biswas, Souvik ; Beach, Aaron...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
2

In vivo CRISPR base editing of PCSK9 durably lowers cholest..:

Musunuru, Kiran ; Chadwick, Alexandra C. ; Mizoguchi, Taiji...
Nature.  593 (2021)  7859 - p. 429-434 , 2021
Link: https://doi.org/10.1038/..
 
?
3

Lipid nanoparticles silence tumor necrosis factor α to impr..:

Kasiewicz, Lisa N. ; Whitehead, Kathryn A.
Bioengineering & Translational Medicine.  4 (2018)  1 - p. 75-82 , 2018
Link: https://doi.org/10.1002/..
 
?
4

Recent advances in biomaterials for the treatment of diabet..:

Kasiewicz, Lisa N. ; Whitehead, Kathryn A.
Biomaterials Science.  5 (2017)  10 - p. 1962-1975 , 2017
Link: https://doi.org/10.1039/..
 
?
5

Silencing TNFα with lipidoid nanoparticles downregulates bo..:

Kasiewicz, Lisa N. ; Whitehead, Kathryn A.
Acta Biomaterialia.  32 (2016)  - p. 120-128 , 2016
Link: https://doi.org/10.1016/..
 
?
6

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepati..:

Kasiewicz, Lisa N ; Biswas, Souvik ; Beach, Aaron...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185539/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Lipid nanoparticles silence tumor necrosis factor α to impr..:

Kasiewicz, Lisa N ; Whitehead, Kathryn A
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336737/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

GalNAc-Lipid nanoparticles enable non-LDLR dependent hepati..:

Lisa N. Kasiewicz ; Souvik Biswas ; Aaron Beach...
https://doi.org/10.1038/s41467-023-37465-1.  , 2023
Link: https://doi.org/10.1038/..
 
?
9

Galectin-3 inhibition with belapectin combined with anti-OX..:

Sturgill, Elizabeth R. ; Rolig, Annah S. ; Linch, Stefanie N....
OncoImmunology.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
10

Combination OX40 agonism/CTLA-4 blockade with HER2 vaccinat..:

Linch, Stefanie N. ; Kasiewicz, Melissa J. ; McNamara, Michael J....
Proceedings of the National Academy of Sciences.  113 (2016)  3 - p. , 2016
Link: https://doi.org/10.1073/..
 
?
11

Combination OX40 agonism/CTLA-4 blockade with HER2 vaccinat..:

Linch, Stefanie N. ; Kasiewicz, Melissa J. ; McNamara, Michael J....
Proceedings of the National Academy of Sciences of the United States of America.  113 (2016)  3 - p. E319-E327 , 2016
Link: https://www.jstor.org/st..
 
?
12

Common gamma chain (γc) cytokines differentially potentiate..:

McNamara, Michael J ; Kasiewicz, Melissa J ; Linch, Stefanie N..
Journal for ImmunoTherapy of Cancer.  2 (2014)  1 - p. , 2014
Link: https://doi.org/10.1186/..
 
?
13

Combination OX40 agonism/CTLA-4 blockade with vaccination r..:

Linch, Stefanie N ; Kasiewicz, Melissa J ; Redmond, William L
Journal for ImmunoTherapy of Cancer.  1 (2013)  S1 - p. , 2013
Link: https://doi.org/10.1186/..
 
?
14

Combined targeting of co-stimulatory (OX40) and co-inhibito..:

Redmond, William L ; Linch, Stefanie N ; Kasiewicz, Melissa J
Journal for ImmunoTherapy of Cancer.  1 (2013)  S1 - p. , 2013
Link: https://doi.org/10.1186/..
 
1-14